Clinical Trials on Relapsed or Refractory Hematologic Malignancies in New Zealand
Total 1388 results
-
Regeneron PharmaceuticalsActive, not recruitingRelapsed and Refractory Multiple Myeloma (RRMM)United States
-
Weill Medical College of Cornell UniversityTerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess BlastsUnited States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada
-
Hangzhou Zenshine Pharmaceuticals Co., Ltd.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Non-hodgkin LymphomaUnited States
-
Ossium Health, Inc.Center for International Blood and Marrow Transplant ResearchRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia | Acute Undifferentiated Leukemia | Acute Biphenotypic LeukemiaUnited States
-
Monash UniversityRecruitingHypogammaglobulinemia | Haematological MalignancyAustralia
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnHemophilia AItaly, United States, Netherlands, United Kingdom, Germany, New Zealand, Belgium, France
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLeukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
AmgenTerminatedMultiple Myeloma | Waldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingRecurrent, Refractory, or High Risk Leukemias | Matched Targeted TherapyUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Northwell HealthNew York Blood CenterCompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Hoffmann-La RocheRecruitingHemophilia ASpain, Canada, United States, New Zealand, Italy, Poland
-
AstraZenecaTerminatedLymphoma | Multiple Myeloma | Advanced Solid Tumors | Hematologic MalignanciesUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
AmgenCompletedLymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade LymphomaUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
Angiocrine BioscienceCalifornia Institute for Regenerative Medicine (CIRM)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia in Remission | Other Acute LeukemiasUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingLymphoma | Refractory | RelapsedUnited States
-
Chimagen Biosciences, LtdRecruitingNon-Hodgkin's Lymphoma (Disorder) | Acute Lymphoid Leukemia, Disease (Disorder)United States
-
Jazz PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Hematologic MalignancyUnited States, Canada
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory Classical Hodgkin LymphomaItaly, United States, United Kingdom, Canada, Spain, France, Denmark
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Sanjay MohanAbbVie; Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cornell UniversityUniversity of RochesterActive, not recruiting
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Gamida Cell ltdCompletedTransplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HMHematological Malignancies | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States, Singapore, Spain, Netherlands, Italy
-
Yale UniversityVanderbilt UniversityCompletedRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Mesoblast, Ltd.CompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Hodgkin's DiseaseUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway